Tridax Procumbens Flavonoids Stimulated Synergistic Effects on BMP-2-Induced Bone Regeneration in Critical-Sized of Calvarial Defect

Bone morphogenetic protein (BMP)-2 is widely used as an effective growth factor to promote bone regeneration for improving bone repair. The ability of BMP-2 to induce bone regeneration relies heavily on requiring large amounts for its short half-life, thereby causing side effects such as cancer and inflammation. Combination therapies using BMP-2 with bioactive agents that can reduce the required amount of BMP-2 have been developed. Recently, we found that Tridax procumbens flavonoids (TPF) stimulated osteoblast differentiation which was demonstrated by increasing of alkaline phosphatase, osteocalcin and type 1 collagen. This study aimed to assess whether TPF elicits synergistic effects on BMP-2 induced local bone regeneration. A calvarial defect model was employed in C57BL/6 male mice. TPF combination with BMP-2 was implanted on the defect sites. The mice were sacrificed on day 28 after implantation. The radiographic and histomorphometric analyses were performed to assess the healing of the defects. The radiographic analyses of the defect sites showed that TPF with BMP-2 group led to higher bone regeneration compared to BMP-2 only group. Histomorphometric analyses showed that the bone regeneration parameters were significantly higher when TPF with BMP-2 was used. Our data suggest that TPF could enhance the stimulatory effects of BMP-2-induced bone regeneration in critical-sized defect of mice.


Introduction
Bone morphogenetic proteins (BMPs), which belong to the transforming growth factor (TGF)-β superfamily, are essential for embryogenesis, chondrogenesis and skeletal development [1,2] which are responsible for fracture repair and regeneration of bone defects [3,4]. Among the BMPs, BMP-2 is one of the most potent inducible growth factor involved in bone formation in vivo [5]. Clinical trials of BMP-2 have demonstrated its role in accelerating bone regeneration during both fracture healing and spinal fusion [6,7]. However, the use of BMP-2 requires large amounts for its short half-life to form bone and it cannot maintain marked osteoinductive effect in vivo [8][9][10].
Furthermore, it is difficult to produce BMP-2 in mass and then put them into broad application in medicine [11,12]. Also, recombinant BMP-2 (RH-BMP-2) is expensive and treatment with high doses is associated with side effects [13,14]. The recent evidence showed that BMP-2 has the potential to cause cancer and retropharyngeal swelling is induced by high doses of rh-BMP-2 [15][16][17]. Therefore, a reduction in the amount of BMP-2 therapy is necessary to reduce its adverse effects and it is necessary to develop an appropriate enhancer of anabolic agents, which can directly stimulate bone formation or at least accelerate BMP-2induced bone formation [18]. Previous studies have shown that natural bioactive compounds, could help in recover fracture as well as bone loss [19,20] and have been found to decrease urinary excretion of calcium and phosphate, increase osteoblast activity, decrease osteoclast activity, and protect against the loss of trabecular thickness either alone or in combination [21,22].
Due to their lack of toxicity and side effects, they are considered to be safer than the chemical synthetic drugs replacement therapy as preventive measures against various diseases including osteoporosis and osteoarthritis [23,24]. Tridax procumbens extracts are known for their traditional medicinal properties to increase osteogenic properties and osteoblasts differentiation in mesenchymal stem cells [25][26][27]. Previously, we showed the inhibitory effects of TPF on osteoclast differentiation and bone resorption. TPF significantly suppressed the receptor activator of nuclear factor kappa-Β ligand (RANKL)-induced differentiation of osteoclasts and formation of pits in primary osteoclasts [28]. We also showed that TPF decreased the expression of osteoclast differentiation-related genes including tartrate-resistant acid phosphatase (Trap), Cathepsin K, matrix metalloproteinases (Mmp)-9 and Mmp-13 in primary osteoclasts [28]. In other studies, reported that TPF promoted osteoblasts differentiation and bone formation in a dose-dependent manner demonstrated by up-regulation of ALP [29,30]. TPF also significantly induced higher bone mass investigated by bone mineral density (BMD) and bone mineral content (BMC) was increased in TPF-treated low calcium diet mice [30]. In the current study, we demonstrated that the combined of TPF with BMP-2 induced higher bone formation activity and bone mass compared to BMP-2 only in a murine calvarial defect model.

Selection of Tridax procumbens
The Tridax procumbens plants are widely available through over the country (Bangladesh). The selection of samples and collection of flavonoids were described elsewhere [28,29] with some modifications. Briefly, it was collected the samples

Sample preparation
Different plant parts of Tridax procumbens (root, stem, leaf, and flowers) were separately shade dried, finely powdered using a sterile blender, and subjected to extraction of flavonoids as described elsewhere [28,29] with some modifications. Briefly, two hundred grams of each finely powdered sample was Soxhlet extracted with 80% hot methanol (1000 ml) on a water bath for to neutrality and dried for further use [28,29]. In this study, we used bound free flavonoid for osteoblast differentiation and bone formation.

Total flavonoids determination
Total flavonoids content of each extract was determined by aluminum chloride as described elsewhere [28,29] with some modifications. Briefly, plant extracts (0.5 ml of 1:10 g/ml) were separately mixed with 1.5 ml of methanol, 0.1 ml of 10% aluminum chloride, 0.1 ml of 1 M potassium acetate and 2.8 ml of distilled water. It remained at room temperature for 30 min. The absorbance of the reaction mixture was measured at 415 nm with a spectrophotometer, and quercetin was used as a standard for the calibration curve. Total flavonoids values are expressed in terms of mg equal quercetin in 1g of powder.

Extraction of chitin from shrimp shell
Chitin was obtained from shrimp shell as described elsewhere [31]. In brief, removal of protein, 40% NaOH (w/v) was added into shrimp shell and the deproteination process was led for 72 hours. After deproteination, the shells were washed with distilled water. Then removal of calcium from these shells was treated with 4% concentrated of HCl and the demineralization time was 20-24 hours and then after demineralization, the shells were washed with distilled water and dried. These deproteinated and decalcified shells are chitin.

Conversion of Chitin to Chitosan
To produce chitosan, dried deproteinated and decalcified chitins were mixed with distriled water. Removal of acetyl groups from distilled water mixed chitin was used 20 M NaOH solution and stirred. The process was carried out for 48 hours.

Preparation of collagen/chitosan containing TPF with BMP-2 discs
Collagen/chitosan discs (3.5 mm in diameter and 2 mm thick) were prepared using biopsy punches (Kai Industries, Gifu, Japan) from collagen/chitosan scaffold. 1 µg of BMP-2 and 1 µg of BMP-2 combined with 0.2 mg of TPF (20 mg/kg) were added to the collagen/chitosan discs. After adding BMP-2 and TPF, the collagen/chitosan discs including carrier control (collagen/chitosan discs without adding any agents) were freeze-dried overnight.

Animals
C57BL/6 male mice were obtained from ICDDR,B (Dhaka, Bangladesh) and maintained in our animal care facilities as described elsewhere [28,30]. The experimental procedures were reviewed and approved by the Animal Care and Use Committee of Rajshahi University, Bangladesh.

Radiographic analyses
Soft X-ray photographs of calvariae were taken using a cabinet X-ray apparatus (type SRO-M50; Sofron, Tokyo, Japan).

Statistical analysis
We used analysis of variance with F-test flowed by SPSS. P values less than 0.05 were considered significant. The data are presented as mean ± standard deviation values of independent replicates.

Effects of TPF on BMP-2 induced bone regeneration
The calvarial defect model was used to clarify whether TPF could increase the effects on BMP-2 induced bone regeneration in vivo.
The soft X-ray and µ-CT images at the defect sites revealed that larger and thicker bone had appeared in the group that received TPF with BMP compared to BMP-2 only group ( Figure 1A, B).
To confirm these radiological observations, the BMC and BMD were measured by using DXA. Both the BMC and BMD were significantly higher in the group treated by TPF with BMP-2 compared to BMP-2 only group ( Figure 1C, D).

Histological observations of the bones in the calvarial defect sites
Further, the regenerated bones of defect sites were clarified by the toluidine blue staining, were significantly larger in the group that received TPF with BMP-2 compared to BMP-2 only group (Figure 2 A, B). The bone histomorphometric analyses showed that the number of osteoblasts (N.Ob), osteoblast surface/bone surface (Ob.S/BS) and bone volume were significantly larger in the group that treated TPF with BMP-2 compared to BMP-2 only group ( Figure 2C, D, E). There were no significant differences in osteoid per bone surface (OS/BS) among the groups received TPF with BMP-2 and BMP-2 only ( Figure 2F).

Effects on bone formation parameters in TPF treated mice
The mineralized areas of the regenerated bones stained by the von-Kossa method were significantly larger in the group that received TPF with BMP-2 compared to BMP-2 only group ( Figure   3A     . The data are expressed as the means ± SD (n=4) for each group. * p<0.05 vs TPF with BMP-2.

Discussion
As described previous, we have shown that the TPF induced osteoblast differentiation which was demonstrated by increasing alkaline phosphatase, osteocalcin, and type 1 collagen. TPF upregulated osteoblast differentiation-related genes, including Alp, osteocalcin, Type 1 collagen, BMP-2, BMP-4 and BMP-7 in primary osteoblasts [29,30]. TPF also increased osteoblast differentiation-related transcription factors, including osterix, and Runx2 in primary osteoblasts [29]. BMD and BMC were significantly increased in low calcium diet mice [30]. In this study, we investigated the effects of TPF on BMP-2-induced bone regeneration by using critical-sized murine calvarial defect. The combined of TPF with BMP-2 led to higher and thicker bone filling the whole bone defect area compared to BMP-2 only (Figure 1). The histomorphometric analyses revealed that higher bone formation activity was seen in the group treated TPF with BMP-2 compared to BMP-2 only (Figure 2, 3), these results suggesting that TPF could be beneficial on BMP-2 induced bone regeneration. In this study, we did not administer TPF systemically, applied TPF with BMP-2 in the carrier to a critical-sized calvarial defect of mice for developing the future applications of bioprospecting natural drugs on local bone regeneration. This is the first study to demonstrate the local administration of TPF stimulated on BMP-2-induced bone formation. Several lines of evidence showed that numer-ous factors and agents, such as fibroblast growth factor (FGF)-2 [32], FGF-4 [33], prostaglandin E 2 receptor agonist [34], TGF-β1 [4] stimulated on BMP-2 induced bone formation. It was reported that at least 5 µg of BMP-2 was optimal to induce bone regeneration [35]. A very little amount of 1 µg of BMP-2 with TPF was used in the present study and radiographically observed that the defect sites almost recovered on day 28 after implantation compared to BMP-2 only group (Figure 1), suggesting that TPF might be a leading therapeutic candidate for developing anabolic agent, which can support on BMP-2 induced bone regeneration. The quantitative measurement of fluorescent-labeled areas of calcein showed that the amount of bone regeneration in the TPF with BMP-2 group could be much larger than that in the BMP-2 only group (Figure 4). On the other hand, the amount of bone volume and mineralization area might also increase in the TPF with BMP-2 administrated group (Figure 3) since the total osteoblast number and osteoclast number/bone surface was higher in the group that received TPF with BMP-2 compared to BMP-2 only group (Figure 2), suggesting that the TPF might be a potential accelerator on BMP-2 induced bone regeneration of this experiment. In this study, we could not directly measure the amount of TPF release to the local bone regeneration sites in vivo.
However, we can speculate on the in vivo kinetics of the TPF release based on the bone formation parameters measured in this study. The newly formed bone continues to be remodeled, resulting in an ossicle. Therefore, the size of the bone is determined J Dent Oral Health 2019 | Vol 6: 204 by the balance between the amount of bone formation and the amount of bone resorption during the experimental period. In our previous study, we showed that TPF significantly suppressed the RANKL-induced osteoclast differentiation and bone resoption [28]. The bone formation activities were measured by using a calcein-based histomorphometric technique. The calcein is absorbed by the bone formation surface at the time of injection, an increase of the MS/BS and BFR, the bone formation parameters, implies that there is an increase in the bone formation activities between the time points of calcein injections, i.e. from day 18 to day 25, suggesting that the osteoclast activity might be the same at the end of the experiment. Furthermore, it is generally difficult to determine the degree of osteoclast function to resorb bone by histological observation. Therefore, we could not evaluate the real balance between bone formation and bone resorption during the bone regeneration process in this study. Further studies are necessary to clarify the mechanism of the anabolic effects of TPF on bone formation.

Conclusion
The present study showed that TPF stimulated BMP-2induced local bone regeneration, even when a minimal amount of BMP-2 was applied. TPF might be a promising natural anabolic agent for supporting BMP induces bone regeneration.